Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.
about
Selective blockade of adrenoceptive beta receptors in the heartComparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in manA third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.Dimethyl isopropylmethoxamine: a selective beta-receptor blocking agentThe anti-inflammatory effect of catecholamines in the peritoneal cavity and hind paw of the mouse.Central and peripheral effects of propranolol and sotalol in normal human subjects.A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animals.A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function.Cellular electrophysiological effects of D- and DL-sotalol in guinea-pig sinoatrial node, atrium and ventricle and human atrium: differential tissue sensitivity.Once daily sotalol in the treatment of hypertension.An evaluation of sotalol, a beta-blocking agent, in patients with angina pectorisElectrocortical changes induced by the perfusion of noradrenaline, acetylcholine and their antagonists directly into the dorsal raphé nucleus of the cat.The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias.A nerve-blocking action of MJ-1999.Effects of catecholamine beta-receptor blocking agents on striated muscle.Noradrenaline and acetylcholine responses of supraoptic neurosecretory cells.The peripheral vascular effects of propranolol and related compounds.Effects of compound MJ-1988 on myocardial contractility, oxygen consumption, coronary blood flow and vascular resistance.The distribution of adrenoceptors and other drug receptors between the two ends of the rat vas deferens as revealed by selective agonists and antagonists.The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol.
P2860
Q28240967-11119B3F-01B1-471D-B6BD-DCF9941BB5EEQ28363254-B76E9023-C2B8-4F22-86BC-DD0B3C43A7A2Q34234794-5611D41B-9E6D-4890-A93E-5EBA897E7577Q34794888-C072C390-9DEA-4261-9AE2-D3E319677CD2Q35174586-4645482B-3AF5-40A1-B41C-884C462CF94BQ35174635-03F7EE34-366D-434C-B37F-6B90050F4093Q35226901-8BAA32A2-EC76-4519-9421-31055A0B5931Q35227162-517CA8D1-9100-4BAC-9C41-2022ACA40346Q35887520-FE4E3BCA-1535-47E6-BEBF-76B0F62F4DF4Q36305336-15DB8E6A-B4ED-4472-A8EA-7C491D898B3CQ36810772-6A09DEA4-8F28-4897-812D-C718C460DF1AQ40027286-D2458CC9-01EE-48F7-8AAE-EC022EB5D03CQ41357289-6A5B1C21-6A39-4604-89FC-57C1EB609934Q41363694-3F223793-EE46-4318-A45E-456411771107Q41366913-100FA3F0-3986-432F-923A-88A28F404EBDQ41512764-BBB594CE-E976-4A93-84E2-D2BC6DA029E7Q41893670-51757DF7-BE41-40BE-8844-6BE98AF55911Q41953531-E6485575-9700-4392-A6FC-AB502CCD38C6Q41981953-9BDC7DA5-D2F1-4F7D-ACF6-1324AC2389C7Q43255348-9BD452D9-64B6-4CF8-9AEF-0F97A2ECB9EC
P2860
Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.
description
1965 nî lūn-bûn
@nan
1965年の論文
@ja
1965年学术文章
@wuu
1965年学术文章
@zh
1965年学术文章
@zh-cn
1965年学术文章
@zh-hans
1965年学术文章
@zh-my
1965年学术文章
@zh-sg
1965年學術文章
@yue
1965年學術文章
@zh-hant
name
Pharmacological and toxicologi ...... renergic receptor antagonists.
@en
Pharmacological and toxicologi ...... renergic receptor antagonists.
@nl
type
label
Pharmacological and toxicologi ...... renergic receptor antagonists.
@en
Pharmacological and toxicologi ...... renergic receptor antagonists.
@nl
prefLabel
Pharmacological and toxicologi ...... renergic receptor antagonists.
@en
Pharmacological and toxicologi ...... renergic receptor antagonists.
@nl
P2093
P1476
Pharmacological and toxicologi ...... drenergic receptor antagonists
@en
P2093
P304
P407
P577
1965-08-01T00:00:00Z